Short answer
Align Technology (ALGN) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). C. Raymond Larkin retires as Chairman July 1, 2026 and leaves the Board December 31, 2026.
Align Technology 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- C. Raymond Larkin retires as Chairman July 1, 2026 and leaves the Board December 31, 2026
- Departure unrelated to disagreements, removal for cause, or operational-policy disputes
- Independent director Kevin Conroy becomes Chairman July 1, 2026
- Leadership transition preserves independent board oversight through Conroy’s appointment
Item 7.01 · Regulation FD Disclosure
- Board leadership transition announced, creating potential governance and strategic oversight changes
- Director Mr. Larkin intends to retire effective December 31, 2026
- Press release furnished as Exhibit 99.1 for transition details and succession implications
Item EX-99.1 · Exhibit EX-99.1
- Board chair transition effective July 1, 2026, with Kevin Conroy succeeding C. Raymond Larkin, Jr
- Larkin remains a director and Governance Committee member through December 31, 2026, supporting continuity
- Conroy’s healthcare, technology, and strategy background strengthens board leadership during Align’s growth phase
- Conroy served as Exact Sciences CEO until its acquisition by Abbott Laboratories in March 2026
- Align reports approximately 299.5 thousand doctor customers and 22.8 million Invisalign patients to date
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Align Technology 8-K filings
Get the next ALGN 8-K as it lands
Follow ALGN for push alerts, or ask the research agent what this filing means.